注射用設備及產品市場:2023年

本報告提供全球注射用設備及產品市場相關調查，各市場區隔概要，新興技術，市場分析與預測，及加入此市場的主要企業簡介等資訊。

目錄

摘要整理

單回用量固定型

• Molly(SHL Medical)
• Molly RNS(SHLMedical)
• Belta(SHL Medical)
• Maggie(SHL Medical)
• Amber(SHL Medical)
• AutoJect 2(Owen Mumford)
• SelfDose(West Pharmaceutical Services)
• DAI(SHL Medical)
• DI 2(SHL Medical)
• Flexi-Q PFS(Elcam Medical)
• fijiojekuto(Becton Dickinson
• intebia(Becton Dickinson)

可變用量型

• VSDI+NIT
• Ypsomed VarioJect

高粘度型

• Rotaject Technology(SHL Medical)
• 再利用筆
• 雙心腔型筆

商務用筆產品

• GENOTROPIN Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo(Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)

副甲狀腺素用

• Forteo Pen
• Preotact/Preos
• Natpara

生殖荷爾蒙用

• Follistim/Puregon Pen
• Gonal-f

穿戴式設備- 分析與評估

• Libertas (Becton Dickinson)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• eLVD Patch Pump (Elcam)
• Ypsomed/Ypsomed 2.25)
• Flexi-Q HV (Elcam Medical)

雙心腔型型

• SDI MIX+NIT(SHL Medical)

無線支援自動注射器

• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)

產品固有的自動注射器

• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)

自動注射器的設計要素

• 材料選擇的問題
• 零件分數和設備成本
• 安全功能
• 針插入深度
• 故障保險裝置活化
• 給藥檢驗、注射確認

市場要素

• 冷凍乾燥藥/重組
• 人因工程/人體工學

筆型注射器

• 筆型注射器的設計選擇要素
• 標準化筆平台
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• 自訂筆設計

新興技術

• 無線資料

注射劑市場分析與預測

• 自體免疫疾病
  • 類風濕性關節炎
  • 乾癬
  • 多發性硬化症
• 造血
  • 荷爾蒙
  • 骨質疏鬆症
  • 妊娠能力

市場要素

• 法規上的問題
• 設備的品牌
• 患者的醫囑遵從性與易用性
• 醫療保健經濟學

企業簡介

“Injectable Drug Devices and Products - 2023” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for injection devices. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

What You Will Learn:

• Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.

• Assesses key markets, market dynamics and market demographics.

• Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.

• Provides market data and forecasts.

• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations

• Assesses the importance of alliances and partnerships on drug product commercialization.

• Evaluates the impact of economic, technology, and regulatory factors.

Table of Contents

Executive Summary

• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Prefilled Syringe Supply Chain
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs
• Proliferation of Biological Drugs
• Therapeutic Monoclonal Antibodies
• Risk Factors
• Injectable Drug Device Summaries
• Autoinjectors

Single Fixed Dose

• Molly (SHL Medical)
• Molly RNS (SHLMedical)
• Bertha (SHL Medical)
• Maggie (SHL Medical)
• Amber (SHL Medical)
• AutoJect 2 (Owen Mumford)
• SelfDose (West Pharmaceutical Services)
• DAI (SHL Medical)
• DI 2 (SHL medical)
• Flexi-Q PFS (Elcam Medical)
• Physioject (Becton DIckinson
• Intevia (Becton Dickinson)

Variable Dosing

• VSDI + NIT
• Ypsomed VarioJect

High Viscosity

• Rotaject Technology (SHL Medical)
• Reusable Pens
• Dual Chamber Pens

Commercial Pen Products

• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo (Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)

Parathyroid Hormone

• Forteo Pen
• Preotact/Preos
• Natpara

Reproductive Hormones

• Follistim/Puregon Pen
• Gonal-f

Wearable Devices - Analysis and Assessments

• Libertas (Becton Dickinson)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• eLVD Patch Pump (Elcam)
• Ypsomed/Ypsomed 2.25)
• Flexi-Q HV (Elcam Medical)

Dual Chamber

• SDI MIX +NIT (SHL Medical)

Wirelessly Enabled Autoinjectors

• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)

Selected Product Specific Autoinjectors

• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)

Autoinjector Device Design Factors

• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation

Market Factors

• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics

Pen Injectors

• Pen Injector Design Selection Factors
• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• Custom Pen Designs

Emerging Technology

• Wireless Data

Injectable Drug Market Analysis and Forecasts

• Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis

• Hematopoietics
  • Hormones
  • Osteoporosis
  • Fertility

Market Factors

• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics

Company Profiles